JPS5813521A - ミエロペルオキシダ−ゼの粉末製剤 - Google Patents

ミエロペルオキシダ−ゼの粉末製剤

Info

Publication number
JPS5813521A
JPS5813521A JP56111017A JP11101781A JPS5813521A JP S5813521 A JPS5813521 A JP S5813521A JP 56111017 A JP56111017 A JP 56111017A JP 11101781 A JP11101781 A JP 11101781A JP S5813521 A JPS5813521 A JP S5813521A
Authority
JP
Japan
Prior art keywords
mpo
albumin
added
myeloperoxidase
freeze
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56111017A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0348173B2 (enExample
Inventor
Ryutaro Yamana
山名　隆太郎
Takashi Kobayashi
隆 小林
Eiichi Hasegawa
栄一 長谷川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Priority to JP56111017A priority Critical patent/JPS5813521A/ja
Publication of JPS5813521A publication Critical patent/JPS5813521A/ja
Publication of JPH0348173B2 publication Critical patent/JPH0348173B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP56111017A 1981-07-16 1981-07-16 ミエロペルオキシダ−ゼの粉末製剤 Granted JPS5813521A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56111017A JPS5813521A (ja) 1981-07-16 1981-07-16 ミエロペルオキシダ−ゼの粉末製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56111017A JPS5813521A (ja) 1981-07-16 1981-07-16 ミエロペルオキシダ−ゼの粉末製剤

Publications (2)

Publication Number Publication Date
JPS5813521A true JPS5813521A (ja) 1983-01-26
JPH0348173B2 JPH0348173B2 (enExample) 1991-07-23

Family

ID=14550279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56111017A Granted JPS5813521A (ja) 1981-07-16 1981-07-16 ミエロペルオキシダ−ゼの粉末製剤

Country Status (1)

Country Link
JP (1) JPS5813521A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108107210A (zh) * 2017-12-18 2018-06-01 广州市进德生物科技有限公司 一种髓过氧化物酶冻干校准品的制备方法及冻干保护液

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54147916A (en) * 1978-05-12 1979-11-19 Sumitomo Chem Co Ltd Preparation of urokinase injection

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54147916A (en) * 1978-05-12 1979-11-19 Sumitomo Chem Co Ltd Preparation of urokinase injection

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108107210A (zh) * 2017-12-18 2018-06-01 广州市进德生物科技有限公司 一种髓过氧化物酶冻干校准品的制备方法及冻干保护液

Also Published As

Publication number Publication date
JPH0348173B2 (enExample) 1991-07-23

Similar Documents

Publication Publication Date Title
Weinberg Nutritional immunity: host's attempt to withhold iron from microbial invaders
TW400234B (en) Pharmaceutical compositions for subcutaneous, intramuscular or intradermal administration containing coagulation factor VIII or factor IX and additive
EP0444692B1 (en) Thrombin composition for oral administration
AU777410C (en) Preserved pharmaceutical formulations
HU227992B1 (en) Interferon conjugates, process for prepairing them, pharmaceutical compositions, containing them and use of them
JPH11509721A (ja) 高純度フォンビルブラント因子の入手方法
US3070499A (en) Parenteral aqueous solutions of fat soluble vitamins
JPH0672105B2 (ja) 血栓溶解剤及びその製法
JPH03170437A (ja) ポリペプチド含有の皮下または筋肉内投与用医薬組成物
JPS6326120B2 (enExample)
JPS592686A (ja) ミエロペルオキシダ−ゼの粉末製剤
JPS59172425A (ja) 新規な血液凝固因子誘導体およびその製造法ならびにそれを含有する血液凝固促進剤
JPH03501604A (ja) ガンマ・インターフェロンの安定化処方
PT759775E (pt) Formulacoes liquidas de ifn-b
Attström et al. Effect of experimental leukopenia on chronic gingival inflammation in dogs: II. Induction of leukopenia by heterologeous anti‐neutrophil serum
US5582821A (en) Methods for treating bleeding disorders
JPS5813521A (ja) ミエロペルオキシダ−ゼの粉末製剤
DE69115011D1 (de) Stabiles mittel auf hämoglobinbasis und verfahren zu dessen einlagerung.
Scatena et al. O-raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrier
RS50355B (sr) Formulacije eritropoietina sa više doza
HU218103B (hu) Nem-glikozilezett, rekombináns humán interleukin-2 redukált alakját tartalmazó, stabilizált gyógyászati készítmény és eljárás előállítására
Green et al. Acetylation of erythrocytic membrane peptides by aspirin
JPS62153224A (ja) プラスミノゲン製剤
JPS62234030A (ja) ｔＰＡ医薬組成物
KR100227453B1 (ko) 개선된 혈액 대용품